Inhibition of cell surface expression by mutant receptors demonstrates that D2 dopamine receptors exist as oligomers in the cell

Molecular Pharmacology

Volumn 58, Issue 1, 2000, Pages 120-128

  Lee, Samuel P ^a   O'Dowd, Brian F ^a,c   Ng, Gordon Y K ^b,e   Varghese, George ^a   Akil, Huda ^d   Mansour, Alfred ^d,f   Nguyen, Tuan ^c   George, Susan R ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d UNIVERSITY OF MICHIGAN   (United States)

^e MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^f Pharmaco Genesis   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; CELL SURFACE RECEPTOR; COMPLEMENTARY DNA; DOPAMINE 2 RECEPTOR; EMONAPRIDE; G PROTEIN COUPLED RECEPTOR; GUANYLYLIMIDODIPHOSPHATE; OLIGOMER; SPIPERONE; TRITIUM;

ANIMAL CELL; ARTICLE; CHO CELL; CONTROLLED STUDY; DIMERIZATION; DRUG RECEPTOR BINDING; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; OLIGOMERIZATION; PHOTOAFFINITY LABELING; POINT MUTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RECEPTOR DENSITY;

EID: 0033924207     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.1.120     Document Type: Article

References (37)

1. AbdAlla S, Zaki E, Lother H and Quitterer U (1999) Involvement of the amino terminus of the B2 receptor in agonist-induced receptor dimerization. J Biol Chem 274:26113-26119.
2. Bai M, Trivedi S and Brown EM (1998) Dimerization of the extracellular calcium-sensing receptor (CaR) on the cell surface of CaR-transfected HEK293 cells. J Biol Chem 273:23605-23610.
3. Benkirane M, Jin DY, Chun RF, Koup RA and Jeang KT (1997) Mechanism of transdominant inhibition of CCR5-mediated HIV-1 infection by ccr5Δ32. J Biol Chem 272:30603-30606.
4. Casey JR and Reithmeier RA (1991) Analysis of the oligomeric state of band 3, the anion transport protein of the human erythrocyte membrane, by size exclusion high performance liquid chromatography. Oligomeric stability and origin of heterogeneity. J Biol Chem 266:15726-15737.
5. Chidiac P, Green MA, Pawagi AB and Wells JW (1997) Cardiac muscarinic receptors. Cooperativity as the basis for multiple states of affinity. Biochemistry 36:7361-7379.
6. Cvejic S and Devi LA (1997) Dimerization of the delta opioid receptor: Implication for a role in receptor internalization. J Biol Chem 272:26959-26964.
7. Fukushima Y, Asano T, Saitoh T, Anai M, Funaki M, Ogihara T, Katagiri H, Matsuhashi N, Yazaki Y and Sugano K (1997) Oligomer formation of histamine H2 receptors expressed in Sf9 and COS-7 cells. FEBS Lett 409:283-286.
8. George SR, Lee SP, Varghese G, Zeman PR, Seeman P, Ng GYK and O'Dowd BF (1998) A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization. J Biol Chem 273:30244-30248.
9. Gouldson PR, Snell CR and Reynolds CA (1997) A new approach to docking in the β2-adrenergic receptor that exploits the domain structure of G protein-coupled receptors. J Med Chem 40:3871-3886.
10. Grigoriadis DE, Niznik HB, Jarvie KR and Seeman P (1988) Glycoprotein nature of D2 dopamine receptors. FEBS Lett 227:220-224.
11. Hebert TE, Moffett S, Morello JP, Loisel TP, Bichet DG, Barret C and Bouvier M (1996) A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. J Biol Chem 271:16384-16392.
12. Jahangeer S and Rodbell M (1993) The disaggregation theory of signal transdnction revisited: Further evidence that G proteins are multimeric and disaggregate to monomers when activated. Proc Natl Acad Sci USA 90:8782-8786.
13. Jones KA, Borowsky B, Tamm JA, Craig DA, Durkin MM, Dai M, Yao WJ, Johnson M, Gunwaldsen C, Huang LY, Tang C, Shen Q, Salon JA, Morse K, Laz T, Smith KE, Nagarathnam D, Noble SA, Branchek TA and Gerald C (1998) GABA(B) receptors function as a heteromeric assembly of the subunits GABA(B)R1 and GABA(B)R2. Nature (Lond) 396:674-679.
14. Kaupmann K, Malitschek B, Schuler V, Heid J, Froestl W, Beck P, Mosbacher J, Bischoff S, Kulik A, Shigemoto R, Karschin A and Bettler B (1998) GABA(B)-receptor subtypes assemble into functional heteromeric complexes. Nature (Lond) 396:683-687.
15. Kobilka BK, Kobilka TS, Daniel K, Regan JW, Caron MG and Lefkowitz RJ (1988) Chimeric alpha 2-, beta 2-adrenergic receptors: Delineation of domains involved in effector coupling and ligand binding specificity. Science (Wash DC) 240:1310-1316.
16. Kuner R, Kohr G, Grunewald S, Eisenhardt G, Bach A and Kornau HC (1999) Role of heteromer formation in GABAB receptor function. Science (Wash DC) 283:74-77.
17. Levey AI, Hersch SM, Rye DB, Sunahara RK, Niznik HB, Kitt CA, Price DL, Maggio R, Brann MR and Ciliax BJ (1993) Localization of D1 and D2 dopamine receptors in brain with subtype-specific antibodies. Proc Natl Acad Sci USA 90:8861-8865.
18. Maggio R, Vogel Z and Wess J (1993a) Coexpression studies with mutant muscarinic/adrenergic receptors provide evidence for intermolecular "cross-talk" between G-protein-linked receptors. Proc Natl Acad Sci USA 90:3103-3107.
19. Maggio R, Vogel Z and Wess J (1993b) Reconstitution of functional muscarinic receptors by co-expression of amino- and carboxyl-terminal receptor fragments. FEBS Lett 319:195-200.
20. Mansour A, Meng F, Meador-Woodruff JH, Taylor LP, Civelli O and Akil H (1992) Site-directed mutagenesis of the human dopamine D2 receptor. Eur J Pharmacol 227:205-214.
21. Marti T (1998) Refolding of bacteriorhodopsin from expressed polypeptide fragments. J Biol Chem 273:9312-9322.
22. Monnot C, Bihoreau C, Conchon S, Curnow KM, Corvol P and Clauser E (1996) Polar residues in the transmembrane domains of the type 1 angiotensin II receptor are required for binding and coupling. Reconstitution of the binding site by co-expression of two deficient mutants. J Biol Chem 271:1507-1513.
23. Ng GY, Clark J, Coulombe N, Ethier N, Hebert TE, Sullivan R, Kargman S, Chateauneuf A, Tsukamoto N, McDonald T, Whiting P, Mezey E, Johnson MP, Liu Q, Kolakowski LF Jr, Evans JF, Bonner TI and O'Neill GP (1999) Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity. J Biol Chem 274:7607-7610.
24. Ng GY, O'Dowd BF, Caron M, Dennis M, Brann MR and George SR (1994) Phosphorylation and palmitoylation of the human D2L dopamine receptor in Sf9 cells. J Neurochem 63:1589-1595.
25. Ng GY, O'Dowd BF, Lee SP, Chung HT, Brann MR, Seeman P and George SR (1996) Dopamine D2 receptor dimers and receptor-blocking peptides. Biochem Biophys Res Commun 227:200-204.
26. Nimchinsky EA, Hof PR, Janssen WG, Morrison JH and Schmauss C (1997) Expression of dopamine D3 receptor dimers and tetramers in brain and in transfected cells. J Biol Chem 272:29229-29237.
27. Ridge KD, Lee SS and Yao LL (1995) In vivo assembly of rhodopsin from polypeptide fragments. Proc Natl Acad Sci USA 92:3204-3208.
28. Romano C, Yang WL and O'Malley KL (1996) Metabotropic glutamate receptor 5 is a disulfide-linked dimer. J Biol Chem 271:28612-28616.
29. Salomon Y, Londos C and Rodbell M (1974) A highly sensitive adenylate cyclase assay. Anal Biochem 58:541-548.
30. Saunders C, Keefer JR, Bonner CA and Limbird LE (1998) Targeting of G protein-coupled receptors to the basolateral surface of polarized renal epithelial cells involves multiple, non-contiguous structural signals. J Biol Chem 273:24196-24206.
31. Schoneberg T, Yun J, Wenkert D and Wess J (1996) Functional rescue of mutant V2 vasopressin receptors causing nephrogenic diabetes insipidus by a co-expressed receptor polypeptide. EMBO J 15:1283-1291.
32. White JH, Wise A, Main MJ, Green A, Fraser NJ, Disney GH, Barnes AA, Emson P, Foord SM and Marshall FH (1998) Heterodimerization is required for the formation of a functional GABA(B) receptor. Nature (Lond) 396:679-682.
33. Wreggett KA and Wells JW (1995) Cooperativity manifest in the binding properties of purified cardiac muscarinic receptors. J Biol Chem 270:22488-22499.
34. Xie Z, Lee SP, O'Dowd BF and George SR (1999) Serotonin 5-HT1B and 5-HT1D receptors form homodimers when expressed alone and heterodimers when co-expressed. FEBS Lett 456:63-67.
35. Zawarynski P, Tallerico T, Seeman P, Lee SP, O'Dowd BF and George SR (1998) Dopamine D2 receptor dimers in human and rat brain. FEBS Lett 441:383-386.
36. Zeng Z, Fan P, Rand E, Kyaw H, Su K, Madike V, Carter KC and Li Y (1998) Cloning of a putative human neurotransmitter receptor expressed in skeletal muscle and brain. Biochem Biophys Res Commun 242:575-678.
37. Zhu X and Wess J (1998) Truncated V2 vasopressin receptors as negative regulators of wild-type V2 receptor function. Biochemistry 37:15773-15784.